• FDA wants a new category of OTC hearing aids for people with mild to moderate hearing losses that generally go without any hearing assistance
• The proposed regulation benefits InnerScope, a direct-to-consumer company selling innovative hearing products, including an FDA-registered Bluetooth app-controlled self-adjusting hearing aids
• InnerScope has made two substantial acquisitions in 45 days, one completed with iHear Medical Inc. and HearingAssist, which expects $150+ million in revenue by 2024 anticipated to close this month.

Historically, hearing aids have been very expensive, bulky, and inexplicably lacking sufficient (if any) insurance coverage. But, finally, times are changing, and the FDA is spearheading a charge towards affordability and accessibility for up to 70 million Americans suffering from impaired hearing. So the timing couldn’t be better for InnerScope Hearing Technologies (OTC: INND) to be innovating in the market, offering its hearing aids and related goods on multiple websites and striking a deal to buy one of the biggest names in the business. Hearing loss is more damaging than may appear at first blush. It is a serious drag on quality of life, causing people to be withdrawn and embarrassed because they can be viewed as confused or uncooperative simply because they can’t hear well. As it happens, people with hearing loss are more than twice as likely (11% vs. 5%) to suffer from depression as the general population. Sadly, only about 1 in 5 people that would benefit from a hearing aid actually seek help, creating a massive void in healthcare. In a landmark proposal, the FDA wants to see a new category of over the counter (“OTC”) hearing aids catering to people with mild to moderate hearing loss that generally go without any hearing assistance. Incidentally, the initiative is personal to Health and Human Services Secretary Xavier Becerra, whose own mother was bilked out of money by an unscrupulous hearing aid manufacturer. The FDA has also set its sights on cracking down on those manufacturers of sound amplification devices skirting regulations to prey on consumers. These regulatory changes, which still must undergo a 90-day comment period before a 60-day implementation deadline, are beneficial to direct-to-consumer specialists like InnerScope, which manufactures, develops, distributes, and sells innovative hearing health-related products, solutions, and treatments, including an FDA-registered Bluetooth app-controlled self-adjusting hearing aids and personal sound amplifiers products. The California-based company has recently launched its world-class hearing aids, and related products on MyHearIQ.com, FSAstore.com, HSAstore.com, and WellDeservedHealth.com, focusing on affordability by targeting consumers enrolled in flexible spending accounts (“FSA”), health saving accounts (“HAS”), and employers’ health incentive programs. InnerScope has partnered with the online retailer and industry leader in the U.S. tax-free healthcare market. Furthermore, the company’s hearing aids and other portfolio products qualify as eligible for FSA and HSA users and are the only company on the retailers’ websites to offer hearing aids. InnerScope’s founders and their heritage has been in the retail hearing device business for 70+ years, is amid a growth phase spurred on by an aggressive growth strategy. On October 5, the company announced it completed an acquisition of iHEAR Medical Inc., a pioneer in online direct-to-consumer hearing solutions with a loyal client base. The merger also widens the InnerScope product bag, including adding iHEARtest(TM), the only FDA-Cleared home hearing screener, advanced FDA-Registered hearing aids, and the TReO(TM) Personal Sound Amplification Product (“PSAP”). iHEAR’s distribution network is diverse, including the likes of CVS Pharmacy, Cardinal Health, AmerisourceBergen, Western States Pharmacy Coalition (WSPC), Good Neighbor Pharmacy, FSA Store, Amazon, Ameritas, and VIA Benefits, to name just a few. On October 19, InnerScope struck another major deal, inking a Letter of Intent to acquire Hearing Assist II LLC. The LOI is expected to follow a definitive agreement with a targeted closing date of November 15, 2021. Founded in Virginia Beach 13 years ago, HearingAssist was years ahead of the Eargo “Heck Yeah!” guy as the first DTC hearing aid company to use mass national television marketing to create a recognizable brand as America’s #1 Affordable Hearing Brand (National Television Commercial). Since its inception, HearingAssist has sold more than 500,000 hearing aids to nearly 400,000 customers via direct-to-consumer or through retail partners. The company sells products via multiple channels, including 757 Walmart stores in five states, and has generated $72+ million in revenue with its national television commercials through July 2021 With the expected OTC Law coming into effect in 2022, HearingAssist brand revenue projections are expected to exceed $150 million annualized by 2024. For more information, visit the company’s website at www.INND.com and the company’s e-commerce website: www.MyHearIQ.com. NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

• The CBD skin-care sector has been projected to reach $1.7 billion by 2025
• Market growth has been driven by rising awareness about the benefits of CBD-infused beauty products.
• Simply Sonoma anticipates releasing an array of face and skin creams, moisturizers and beauty products.

Interest in cannabidiol, or CBD, is exploding as the substance has been shown to have myriad benefits. A chemical derived from cannabis, CBD has been included in everything from gummies to dog treats and more. One of the sectors showing impressive potential is skin care, a market that has been projected to reach $1.7 billion by 2025 (https://ibn.fm/a33ND). Simply Sonoma is positioning itself as a strong player in the field as the company focuses on the development of a wide array of skin-care products. “The global CBD skincare market size was estimated at USD$234.1 million in 2018 and is projected to grow at a CAGR of 32.9% over the forecasted period, from 2019 to 2025,” a Million Insights article reported. “The market growth has been majorly driven due to rising awareness about the benefits of CBD-infused beauty products. . . “Cannabidiol is gaining popularity due to its relaxing, anti-anxiety and pain-relieving properties,” the article continued. “The growing adoption of CBD-infused skincare products in developed regions supported by the legalization of cannabis cultivation is projected to drive the market growth over the forecast period.” The article noted that CBD-based beauty products are effective and safe for all skin types. “[CBD] is highly beneficial to people who are facing acne, dryness, inflammation and sensitive skin problems,” Million Insights observed. “Due to its high inflammatory property, CBD is used for the skin’s natural healing process and reducing breakouts. It also acts as an antioxidant that helps in reducing early signs of aging and reduces the pain caused by inflammatory skin problems.” Companies eyeing growth opportunities in the space are looking at offering CBD-infused oils, creams and moisturizers, serums and masks, cleansers and more. According to Million Insights, the skin-care oil category is the largest piece of the CBD skin-care pie, coming in at 41% market share in 2018. However, while oils remain strong, masks and serums are projected to see the CAGR, projected to be more than 33.5% from 2019 to 2025. “The CBD-based serum and mask are expected to gain a significant share over the forecast period. This scenario is anticipated to boost the product demand among consumers owing to its easy application and deep absorption in the skin,” the reported stated. Simply Sonoma is looking to leverage its CBD expertise as it develops an organic beauty product line. The company anticipates releasing an array of face and skin creams, moisturizers and beauty products (https://ibn.fm/fx1Tk). Simply Sonoma is a different kind of natural company. The company is committed to creating high-quality products using all-natural, organically sun-grown, plant-based ingredients. In addition, because the company is committed to minimizing its carbon footprint, it operates off the grid, relying on solar power. For more information, or to invest in Simply Sonoma, visit the company’s website at www.SimplySonoma.org. NOTE TO INVESTORS: The latest news and updates relating to Simply Sonoma are available in the company’s newsroom at https://ibn.fm/Sonoma

• SRAX hosted the 2021 LD Micro Main Event between October 12-14, 2021
• Marking a return to an in-person conference after nearly 2 years, the event was held at both, Los Angeles’ Luxe Sunset Bel Air Hotel as well as in a virtual format
• The conference featured 139 companies in attendance, each of whom carried out a 25-minute presentation for the public
• The LD Micro Main Event is the latest highlight within an extensive conference series designed by SRAX and Sequire to offer added value to their burgeoning investor community.

SRAX (NASDAQ: SRAX), a digital marketing pioneer focused on providing consumer data management services, has announced the successful conclusion of the 2021 LD Micro Main Event, which was held in a simultaneous fashion, both in-person at Los Angeles’ Luxe Sunset Bel Air Hotel as well as in a virtual format, through the company’s dedicated Sequire Virtual Events platform between October 12-14, 2021 (https://ibn.fm/v8K02). LD Micro was founded by Chris Lahiji in 2006 for the sole purpose of being an independent resource in the microcap space. Having started life as a newsletter focused on companies with small and mid-cap market capitalizations, LD Micro has grown into a well-respected data and event company, having hosted over 1,600 companies at its various events since the conference series’ inception in 2008. In addition to providing investors with access to unique investment gems, the events have also served to provide exposure to companies that have gone on to great success, including the likes of OptimizeRx Corp. (NASDAQ: OPRX), which replaced Lydall Inc. (NYSE: LDL) in the S&P SmallCap 600 on Monday, October 4th, 2021. This year’s three-day event marked a return to an in-person format for the LD Micro Conference after nearly two years, and featured 139 companies in attendance, each of whom carried out a 25-minute presentation in both in-person and virtual formats, thus catering to thousands of conference delegates in attendance. The following list depicts some of the most viewed company presentations at this year’s conference:

• NaturalShrimp (OTCQB: SHMP)
• Brainchip Holdings (OTCQX: BRCHF)
• Aehr Test Systems (NASDAQ: AEHR)
• Predictmedix (OTCQB: PMEDF)
• Lightwave Logic (NASDAQ: LWLG)
• Humanigen (NASDAQ: HGEN)

SRAX has revealed that all presenting company video calls will be available to view for a period of 3 months. Interested viewers can visit the event website to see all of the presentations: https://ldmicrojune2021.mysequire.com/ Boasting a network of over three million influential, forward-thinking investors and shareholders, the Sequire platform has established a robust reputation as a venue where investors can congregate to learn, share, and network on a wide range of industry related topics. The LD Micro Main Event is the latest highlight within an extensive conference series designed by SRAX and Sequire to offer added value to their budding investor community. For more information, visit the company’s website at www.SRAX.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• StraightUp has entered an ROE with Premier Silver Corp. that secures it 60 days of exclusivity to negotiate an agreement on the acquisition of Premier and its underlying assets
• Premier’s acquisition would give StraightUp a shot at tremendous upside potential in silver exploration and building assets where silver forms the primary product in mining the material
• Premier is a crucial player in the junior mining industry, having raised over $10 million in private funding to date
• Its main asset, the Mallay Mine & Processing Plant, is one of the largest silver mining packages in Peru

StraightUp Resources (CSE: ST) has been on a mission to expand its market reach and grow its mineral exploration domain, primarily through acquisitions. In 2021 alone, the company has added the West Cat Mine, a historic mine in Nevada, to its property portfolio. It is a significant move on its part and one that places it among some of the top players in this sector (https://ibn.fm/scIaX). In a move to further expand this portfolio, StraightUp has announced having entered into a right of exclusivity agreement (“ROE”) with Premier Silver Corp, where the latter is set to acquire all of Premier’s outstanding shares from current shareholders (https://ibn.fm/pO4W1). The ROE provides StraightUp and Premier with the opportunity to exclusively negotiate an agreement on the acquisition of Premier and its underlying assets over the period of 60 days. This period will involve the completion of further due diligence on any ongoing project(s) and the company itself, as well as the negotiations of the terms of a definitive purchase agreement with Premier. Premier Silver Corp has been a significant player in the junior mining industry. Formed by a group with combined 100-plus years of experience, the company has created over $1 billion in shareholder value and raised over $700 million in capital. In 2020, Premier concluded commercial discussions with NYSE-listed Buenaventura (NYSE: BVN) and acquired one of Peru’s largest silver mining land packages- the Mallay Mine & Processing Plant. Premier also acquired over $120 million in capitalized expenditures, coupled with Mallay’s exploration and development assets. Located just four to five hours’ drive north of Lima, the Mallay plant was constructed between 2010 and 2011 at the cost of $128 million, making it a vital asset of the Mallay Property. StraightUp is confident that this acquisition will provide an opportunity for further exploration while also allowing it to position itself among key mining companies within the industry. Mark Brezer, the President and Chief Executive Officer (“CEO”) of StraightUp, reckoned, “Premier Silver is a turnkey operation while providing an opportunity for further exploration. StraightUp has again positioned itself among major mining companies and their projects.” Peru currently has more silver resources than any other country. It is also ranked second in the world in silver production. Silver is also one of the most undervalued commodities globally, which offers a tremendous opportunity and a significant upside for StraightUp, not just in silver exploration but also in building assets where silver forms the primary product in mining the material. “Taking a stake in a country that contains more silver resources than any other country and is ranked second in the world for production gives us a shot at tremendous upside potential, especially if we see a strong decade ahead for metals. We are optimistic our companies can synchronize to mutually benefit one another and shareholders alike,” added Mr. Brezer. Premier was initially created to identify and acquire a de-risked project designed to offer shareholders access to silver. The company recognized that the junior mining market had started to search for projects quick to cash flow, hence its investment in Mallay. Its assets, so far, have placed the company in a unique position to offer leveraged market exposure to the silver industry, as has been demonstrated by raising over $10 million in private funding to date. “I look forward to continuing our discussions with StraightUp in progressing due diligence and potential corporate transactions,” noted Duncan Gordon, the founder and chairman of Premier Silver Corp. StraightUp’s board of directors has, however, not provided any assurance that the ROE will result in a corporate transaction with Premier. For more information, visit the company’s website at www.StraightUpResources.com. NOTE TO INVESTORS: The latest news and updates relating to ST are available in the company’s newsroom at https://ibn.fm/STR

• Assembly Bill 45 provide clarity for the hemp industry and reassures consumers that products are independently tested and labeled properly
• Bill allows the sale of hemp-derived extracts that comply with testing and labeling standards
• SGMD, Nug Avenue committed to providing convenient mobile ordering and online access to its exclusive, quality products

Keeping in line with its reputation for leading the way forward in cannabis acceptance and legislation, California lawmakers and government officials have approved an historic hemp bill (https://ibn.fm/nOjeK). The bill — Assembly Bill 45 (AB-45) — creates a comprehensive regulatory framework for the manufacture and sale of hemp-derived products in the state. California-based companies that are committed to providing high-quality product and excellent services, such as Sugarmade (OTC: SGMD), welcome the legislation, which went into effect immediately. “While CBD products are freely found in stores, they are considered ‘adulterated’ under existing California law, which is defined under the Sherman Food, Drug, and Cosmetic Law,” stated a “High Times” article reporting the legislative news. “What AB-45 will do is provide clarity for the hemp industry  — more importantly, reassuring hemp consumers that products are independently tested and labeled properly.” Other leaders in hemp celebrated the bill as well. “California has been an industry leader in both cannabis and hemp throughout the years but not without its shortcomings and challenges,” Blake Schroeder, CEO of Medical Marijuana, Inc. told High Times. “We have witnessed the many back-and-forth debates with respect to hemp and CBD, even after its federal legality was outlined by the 2018 Farm Bill,” said Blake Schroeder, CEO of Medical Marijuana Inc. “We welcome the new focus on safety and consistency set by AB-45. Our company created many of the testing standards that most major players in the industry still use today. We hope that this bill helps weed out the companies that are selling fake or inaccurately labeled products.” The bill, which California Governor Gavin Newsom signed on Oct. 6, 2021, explicitly allows the sale of hemp-derived extracts that comply with testing and labeling standards, most notably CBD. Sugarmade is a majority owner and operator (70%) of Nug Avenue, a cannabis-delivery services based in southern California that offers hand-selected, top-shelf products. The company is committed to providing convenient mobile ordering and online access to its exclusive, quality products. In addition, the company is focused on strategic growth and expansion, with an in-house tech team that is dedicated to developing next-generation cannabis delivery experience. For more information, visit the company’s website at www.Sugarmade.com. NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SGMD

• Tingo Mobile Plc, subsidiary of leading African agri-fintech, joins forces with Visa to enhance financial services offering and drive greater adoption on its platforms
• Two companies share vision of bringing empowerment through access to financial services; financial inclusion is key to reducing poverty
• Visa is expected to help enhance Tingo’s presence in Nigeria and drive expansion across the African continent and beyond

The leading agri-fintech in Africa, Tingo (OTCQB: IWBB) partners with Visa Inc., in an effort to augment its offerings across Nigerian financial services and expand its market reach across Africa—the second-largest continent by population (https://ibn.fm/exiGe). With its unique rural community’s focus, Tingo’s vision is to deliver a powerful social impact through financial inclusion while becoming Africa’s leading agri-fintech business. The company remains to transforming rural farming communities—one of the most underserved segments of the market—by connecting them through its proprietary platform, thus helping them generate sustainable income. Growing the agricultural sector in Africa is key to reducing poverty and delivering a transformational impact through greater opportunities. The agriculture sector generates around 30–40% of gross domestic product and employs 65–70% of the total labor force in Africa (https://ibn.fm/R2bMY). Financial inclusion, one of the core Sustainable Development Goals, also helps eradicate poverty. Access to financial services simplifies day-to-day living and allows businesses and families to make long-term plans and cover unexpected emergencies. The problem of financial inclusion—or the lack of it—is especially acute in Africa, as almost half of the population does not have access to formal financial services. For example, in 2020, around 56% of Nigerian adults didn’t have access to traditional financial services (https://ibn.fm/O7VOn). To expand its market footprint across Africa and continue developing the business in Nigeria, Tingo partnered with the world’s heavyweight in the payment space, Visa. The partnership is intended to enhance the offering of financial services on Tingo’s platforms and drive their greater adoption, especially digital payments. With a shared vision to enable individuals, businesses, and economies to thrive through financial services, Visa is expected to be a powerful lever to drive Tingo’s expansion across the African continent and beyond. “With this agreement, Tingo Mobile will be able to issue Visa cards (both physical and virtual) to users on Nwassa and Tingo Pay.” Nwassa is Tingo’s digital marketplace platform connecting African farmers with other players in the agricultural value chain and Tingo Pay is the company’s proprietary payment platform available to the public. But the partnership will not stop there. Committed to financial education, Tingo aims to increase financial literacy and greater economic independence across the continent, for which alliance with Visa will be crucial. Tingo and Visa will join forces to deliver knowledge and learning tools to empower communities with adequate information so that they can fully leverage the benefits of increased access to financial services. Visa appears equally optimistic about the upcoming collaboration as this global payment’s leader views partnerships with companies such as Tingo as essential to its business model. “Whether it is changing the way people invest, manage money, receive loans or send real-time payments to friends and family, Visa is a natural partner for fintech companies, providing them with new ways to reach their customers through Visa’s vast network and global scale.”, said Otto Williams, Senior Vice President, Head of Products and Solutions for Visa Central and Eastern Europe, Middle East and Africa. Tingo remains committed to innovation and expansion of services across the continent. What started as a vision to build an ecosystem that supports the largely unbanked agricultural sector in Nigeria 20 years ago now is a business with $600 million in annual revenues and almost 10 million users (https://ibn.fm/bK4WG). The company appears confident that the growth will continue. For more information, visit the company’s website at www.TingoGroup.com. NOTE TO INVESTORS: The latest news and updates relating to IWBB are available in the company’s newsroom at https://ibn.fm/IWBB

• German Social Democrat-led coalition expected to liberalize medical cannabis market
• Analysts predict over one million medical cannabis patients in Germany by 2024, market estimated to reach $8.9 billion by 2028
• RYAH entered German market via observational study with Four 20 Pharma GmbH
• RYAH provides IoT product ecosystem of volume-control devices, medicine-carrying components, mobile applications
• RYAH ecosystem offers reliable way for researchers and clinicians to develop well-controlled research environments

Germany’s recent 2021 election is expected to result in a new political environment via a coalition containing cannabis-positive political factions that aim to liberalize the country’s plant-based medicine market (https://ibn.fm/t1Zgg). RYAH Group (CSE: RYAH), the leader in volume-control technology for plant-based medicine, is already on track to penetrate the German market with a strategic partnership aiming to catalyze the company’s mission of providing remote-health solutions and analytics-based patient treatments to the world. Germany’s winning party – the Social Democrats – are currently in talks with the Greens and Free Democratic Party to form a coalition to replace Angela Merkel’s current government. A pre-election analysis by Volt Face revealed that the Social Democrats “can generally be considered pro-cannabis policy reform,” with even greater pro-cannabis sentiment among the other members of the proposed coalition (https://ibn.fm/PpZMv). Though access to cannabis in Germany may be limited, the current system appears to be serving as a model for the rest of the European Union through policies that demonstrate a controlled, prescribed, and relatively efficient medical cannabis market (https://ibn.fm/kGG8F). Recent reports by the Prohibition Partners organization, based on translated publications from the German Bundestag, provided positive insights into the German medical cannabis model and possible implications for the rest of the European Union. According to the report, there are slightly more than 13,000 complete patient records from roughly 128,000 patients receiving medical cannabis in the country. Market analysts predict one million medical cannabis patients in Germany by 2024 with a total market value of $8.9 billion by 2028, making it one of “the world’s most valuable medical cannabis markets,” according to the New Frontier Data organization. “Germany represents one of the most important and influential plant-based medicine markets in Europe, and we are thrilled to be initiating a pilot program with Four 20 Pharma GmbH in the region,” said Gregory Wagner, RYAH Group CEO. “Four 20 has a strong network of doctors and patient care facilities, making it an excellent partner to pilot RYAH’s smart inhaler and proprietary data analytics as the industry moves towards perfecting prescribing practices and patient regimens.” RYAH provides an ecosystem of IoT products that include volume-control devices, medicine-carrying components, and mobile applications. Used together, they can provide a reliable way for researchers and clinicians to develop well-controlled environments to study the use of cannabis for chronic medical conditions and palliative care. Along with treatment administration, RYAH’s infrastructure aims to generate AI-powered models that can provide precision treatments for various diseases. RYAH is dedicated to leveraging technological innovation that unlocks the power of data to provide better patient outcomes. The company’s robust intellectual property portfolio, comprised of AI-powered technology and portable, cost-effective products, is positioning the company to capture and capitalize on growth opportunities in Germany, the European Union, and beyond. For more information, visit the company’s website at www.RYAHGroup.com. NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://ibn.fm/RYAH

• INND appears committed to creating a leadership dream team announcing Adnan Shennib as the Company’s CTO and president of international operations
• Shennib is a proven leader and entrepreneur in hearing medical devices; he developed several commercially successful hearing innovations
• INND is poised to leverage Shennib’s invaluable insight and expertise to develop new disruptive products and expand Company’s partnerships around the world

InnerScope Hearing Technologies (OTC: INND) has announced that Adnan Shennib, a seasoned industry professional, will join as chief technology officer (“CTO”) and the president of international operations responsible for expanding the Company’s partnerships with manufacturers, distributors, and innovators worldwide. As an industry veteran with over 30 years of experience in hearing innovations, Shennib brings unmatched technology and business competence to solidify InnerScope’s leadership position in the hearing aid market (https://ibn.fm/90eGC). Shennib’s unique background includes leading positions with notable hearing aid manufacturers. One of them is ReSound(R), an industry champion that developed the world’s first remotely controlled hearing aid product. But Shennib is much more than an executive with significant experience in the hearing aids sector. Over the years, he became a well-known Silicon Valley medical device entrepreneur with several commercially successful hearing innovations under his belt. He is also a praised innovator who developed novel hearing solutions that went on to receive the Medical Device Excellence Award and become featured by major media outlets, including CNN, The New York Times, The Dr. Oz Show, USA Today, and Inc. Magazine. He also founded InSound Medical, a company that invented the Lyric(R) hearing device, the first invisible, extended-wear hearing aid, which Sonova-Phonak(R) acquired in 2010 in a deal valued at $169 million. His entrepreneurial endeavors also include iHEAR Medical Inc., a company with a demonstrated track record in bringing novel hearing solutions to the market. There he led the development of several revolutionary innovations, including a groundbreaking online platform for the direct-to-consumer hearing market and, and iHEARtest(TM), the only FDA-cleared home hearing test. Shennib joins the Company through iHEAR Medical Inc. as InnerScope recently acquired the latter. InnerScope is optimistic that the addition of Shennib to the leadership team will help the Company develop new and improved products that can successfully challenge conventional hearing aids. “We are proud to add Mr. Shennib to our team of seasoned experts as InnerScope’s CTO. Mr. Shennib is a pioneer in the hearing industry with a proven track record of developing patentable, groundbreaking discoveries in hearing technology. With our recent acquisition of iHEAR, we are especially excited for Mr. Shennib to lead InnerScope’s new research and development team at our new FDA-registered manufacturing facility in San Leandro, California.” stated Matthew Moore, president and CEO of InnerScope. Shennib appears equally enthusiastic about the new role. “I am excited to join the InnerScope team to advance its mission of providing affordable advanced hearing solutions,” he said, concluding that the initial focus will be on developing products based on new understandings of consumer trends and behavior. InnerScope launched its hearing aids on FSAstore.com, HSAstore.com, and WellDeservedHealth.com to consumers enrolled in flexible spending accounts (“FSA”), health saving accounts (“HSA”), and employers’ health incentive programs. For more information, visit the company’s website at www.INND.com and the company’s e-commerce website: www.MyHearIQ.com. NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

• September 2021 saw four new additions to FuelPositive’s management team
• Each of the new appointments brings with them decades of experience, technical know-how and strategic approaches that will guide the company’s future decisions and investments
• Ian Clifford, FuelPositive’s CEO and chair, has acknowledged that some of these appointments have come at “just the right time”

Ian Clifford, the chief executive officer and chair of the board at FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), while appearing in an interview on the company’s YouTube channel, expressed his optimism and enthusiasm about four new appointments the company made over the month of September. “It’s just a great day for us to add to our already stellar team four new faces with such a broad range of skills and backgrounds. All of these people are key team players for us, so we’re really pleased with this announcement,” he noted (https://ibn.fm/c2Zi9). Clifford acknowledged the value that the four will be bringing to the table, ranging from decades of experience to an intimate understanding of how the industry works. This is particularly useful since the company is no longer solely an R&D company, but rather an enterprise that is working towards ensuring the excellence of its work as it commercializes its lead technology — modular and scalable carbon-free ammonia (“NH3”) (https://ibn.fm/HTKGe). In the interview, Clifford pointed out Olushola (Shola) Ashiru’s long-term support of FuelPositive. He noted the tremendous value she will bring, owing to her understanding of the United States capital markets, ultimately offering perspective into the company’s future environmental investments. This, he acknowledged, complements Nelson Leite’s decades of experience in sophisticated mass production, sales, marketing and engineering as he assumes the new role of chief operating officer (“COO”) of the company. Nelson will play an integral role in building FuelPositive’s phase 2 demonstration systems scheduled for delivery throughout 2022. “Also, as we build those phase 2 systems, we’re going to be looking at mass production manufacturing and what we need to do in order to set that up. Nelson has systems that he’s developed and built with the likes of Toyota, Tesla and other extremely sophisticated manufacturers, so he’ll be a tremendous addition to the team,” Clifford reckoned (https://ibn.fm/c2Zi9). Just like Shola, Francois Desloges, who joins FuelPositive’s executive leadership, has been involved in the company in different capacities over the years. Clifford recognized his skill as a research analyst and scientist, noting that he will be vital in advancing a lot of the various subtle technologies that will be spinning out of the company’s core carbon-free ammonia technology. Lastly, Clifford highlighted Jennifer Spencer’s appointment into the company’s executive leadership team. With her decades of experience in public relations, Clifford believes that she will be able to craft messages that multiple audiences worldwide can understand. Her appointment is founded on the importance of explaining and educating the public about the impact of FuelPositive’s technology, thereby demystifying any myths surrounding it and bringing it closer to the people. Jennifer will also work closely with the company’s consultants and strategic suppliers, ensuring that the message is consistent across all the different audiences. “(Jennifer is) Another great addition to the team at just the right time as the message is getting out,” Clifford noted (https://ibn.fm/c2Zi9). These new appointments are in line with FuelPositive’s ambitious move towards growing its market share and diversifying its revenue streams from a solely R&D company. The additions will help steer the company in the right direction, even as it works towards achieving both the short-term and long-term goals it has set so far. You can watch the whole interview with Ian Clifford here https://ibn.fm/c2Zi9. For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• Mydecine just announced the successful synthesis of a novel psilocin analogue, a tryptamine
• The achievement adds to the company’s library of patent-pending tryptamines for medical use and therapy, and is seen as verifying the value of Mydecine’s AI-driven drug discovery program
• Mydecine has also confirmed its participation in the Wonderland: Miami psychedelic medicine event scheduled for November 8-9, 2021, where the company will share its recent research advancements and goals going forward

Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) just announced the successful synthesis of a novel psilocin analogue, a tryptamine, that has proven to have improved pharmaceutical properties (https://ibn.fm/I2lX7). The success of this study adds to Mydecine’s library of patent-pending tryptamines while also building upon the company’s strategy to enhance the safety and efficacy of its drug development candidates for both medical use and therapy. Mydecine has been a biotechnology and digital tech pioneer, pushing boundaries with its AI-driven drug discovery program. The integration of AI technology, which is currently done in partnership with Applied Pharmaceutical Innovation (“API”) at the University of Alberta, has accelerated the company’s natural product research and novel drug design. This move has also allowed it to scale much faster than would have been possible had Mydecine opted for traditional research methods. Dr. Khaled Barakat, the Principal Investigator at API and University of Alberta Associate Professor, noted, “Our AI technologies construct billions of new drug candidates and filter them for their ability to modulate the activity of the psychedelic-related targets. These AI models also predict the interactions and affinity of each drug candidate to the level of a single atom.” “By considering the unique structural and dynamical fingerprint of each target, our AI-drug discovery program paves the road towards designing selective modulators, hence, reducing any potential side effects that may emerge in the future,” he added. Mydecine’s addition of this compound has demonstrated the company’s ability to achieve proven principles of drug chemistry, time course of action, improved delivery, and compound stability. More importantly, the technology has helped with the effective production of an extensive base of preclinical, in vitro data which is integral to the company’s expansion of its drug pipeline. While making the announcement, Rob Roscow, Mydecine’s Chief Scientific Officer (“CSO”), noted, “Our ability to rapidly uncover safer and more efficacious novel compounds, such as this psilocin analogue, is a true testament to the value and success of our AI-driven drug discovery program. As we progress forward, we see great value from this development as we can now leverage the achieved receptor binding data for serotonin receptor (5-HT2A) and expand our drug pipeline focusing on the agonistic activity of psilocin and other tryptamines at different ratios on serotonin receptors.” Since it was founded in 2020, Mydecine has operated on the guiding principle that there is a significant unmet need and lack of innovations within the therapeutic and mental health environments. Through technology, the company hopes to remedy this situation. This recent milestone demonstrates what the company can do and the fact that there are potential psychedelic-based solutions for mental health and addiction. Mydecine will share this and other achievements at this year’s Wonderland Miami event, scheduled for November 8-9, an event dubbed as the largest psychedelic medicine business event ever put together (https://ibn.fm/b1YEZ). The event will be held at the Adrienne Arsht Center for the Performing Arts in Miami, Florida, and Mydecine expects to share its technological advancements, recent discoveries, and goals. For more information about the event, please visit the event’s website at www.microdose.buzz/wonderland/miami For more information, visit the company’s website at www.Mydecine.com. NOTE TO INVESTORS: The latest news and updates relating to MYCOF are available in the company’s newsroom at https://ibn.fm/MYCOF